PURPOSE: Evidence suggests that women with type 2 diabetes may be at increased risk of breast cancer, possibly due to chronic exposure to insulin resistance and/or hyperinsulinemia. The purpose of this study was to compare the incidence of breast cancer in postmenopausal women with and without diabetes. METHODS: Using population-based validated health databases from Ontario, Canada, this retrospective cohort study compared breast cancer incidence between women, aged 55-79 years, with newly diagnosed diabetes (n=73,796) to women without diabetes (n=391,714). RESULTS: Women with diabetes were slightly older, were more likely to reside in a lower income neighborhood, had greater comorbidity, and had more annual physician visits than women without diabetes. After 2.2 million person-years of follow-up from 1994 to 2002, breast cancer incidence was 2.97/1000 person-years in the diabetes group and 2.75/1000 person-years in the non-diabetes group. After adjustment for age and income, there was a significant increase in breast cancer among women with diabetes (hazard ratio, HR, 1.08, 95% confidence interval, CI, 1.01-1.16, p=0.021). CONCLUSION: This study found a small but significant increase in incident breast cancer in a predominantly postmenopausal population of women with diabetes, when compared to women without diabetes. These results support the possibility that insulin resistance or some other aspect of type 2 diabetes may promote breast cancer, and may further direct treatment and prevention strategies.
PURPOSE: Evidence suggests that women with type 2 diabetes may be at increased risk of breast cancer, possibly due to chronic exposure to insulin resistance and/or hyperinsulinemia. The purpose of this study was to compare the incidence of breast cancer in postmenopausal women with and without diabetes. METHODS: Using population-based validated health databases from Ontario, Canada, this retrospective cohort study compared breast cancer incidence between women, aged 55-79 years, with newly diagnosed diabetes (n=73,796) to women without diabetes (n=391,714). RESULTS:Women with diabetes were slightly older, were more likely to reside in a lower income neighborhood, had greater comorbidity, and had more annual physician visits than women without diabetes. After 2.2 million person-years of follow-up from 1994 to 2002, breast cancer incidence was 2.97/1000 person-years in the diabetes group and 2.75/1000 person-years in the non-diabetes group. After adjustment for age and income, there was a significant increase in breast cancer among women with diabetes (hazard ratio, HR, 1.08, 95% confidence interval, CI, 1.01-1.16, p=0.021). CONCLUSION: This study found a small but significant increase in incident breast cancer in a predominantly postmenopausal population of women with diabetes, when compared to women without diabetes. These results support the possibility that insulin resistance or some other aspect of type 2 diabetes may promote breast cancer, and may further direct treatment and prevention strategies.
Authors: Zhiguo Zhao; Wanqing Wen; Kyriaki Michailidou; Manjeet K Bolla; Qin Wang; Ben Zhang; Jirong Long; Xiao-Ou Shu; Marjanka K Schmidt; Roger L Milne; Montserrat García-Closas; Jenny Chang-Claude; Sara Lindstrom; Stig E Bojesen; Habibul Ahsan; Kristiina Aittomäki; Irene L Andrulis; Hoda Anton-Culver; Volker Arndt; Matthias W Beckmann; Alicia Beeghly-Fadiel; Javier Benitez; Carl Blomqvist; Natalia V Bogdanova; Anne-Lise Børresen-Dale; Judith Brand; Hiltrud Brauch; Hermann Brenner; Barbara Burwinkel; Qiuyin Cai; Graham Casey; Georgia Chenevix-Trench; Fergus J Couch; Angela Cox; Simon S Cross; Kamila Czene; Thilo Dörk; Martine Dumont; Peter A Fasching; Jonine Figueroa; Dieter Flesch-Janys; Olivia Fletcher; Henrik Flyger; Florentia Fostira; Marilie Gammon; Graham G Giles; Pascal Guénel; Christopher A Haiman; Ute Hamann; Patricia Harrington; Mikael Hartman; Maartje J Hooning; John L Hopper; Anna Jakubowska; Farzana Jasmine; Esther M John; Nichola Johnson; Maria Kabisch; Sofia Khan; Muhammad Kibriya; Julia A Knight; Veli-Matti Kosma; Mieke Kriege; Vessela Kristensen; Loic Le Marchand; Eunjung Lee; Jingmei Li; Annika Lindblom; Artitaya Lophatananon; Robert Luben; Jan Lubinski; Kathleen E Malone; Arto Mannermaa; Siranoush Manoukian; Sara Margolin; Frederik Marme; Catriona McLean; Hanne Meijers-Heijboer; Alfons Meindl; Hui Miao; Kenneth Muir; Susan L Neuhausen; Heli Nevanlinna; Patrick Neven; Janet E Olson; Barbara Perkins; Paolo Peterlongo; Kelly-Anne Phillips; Katri Pylkäs; Anja Rudolph; Regina Santella; Elinor J Sawyer; Rita K Schmutzler; Minouk Schoemaker; Mitul Shah; Martha Shrubsole; Melissa C Southey; Anthony J Swerdlow; Amanda E Toland; Ian Tomlinson; Diana Torres; Thérèse Truong; Giske Ursin; Rob B Van Der Luijt; Senno Verhoef; Shan Wang-Gohrke; Alice S Whittemore; Robert Winqvist; M Pilar Zamora; Hui Zhao; Alison M Dunning; Jacques Simard; Per Hall; Peter Kraft; Paul Pharoah; David Hunter; Douglas F Easton; Wei Zheng Journal: Cancer Causes Control Date: 2016-04-06 Impact factor: 2.506
Authors: Andréia Vasconcelos-Dos-Santos; Rafaela Muniz de Queiroz; Bruno da Costa Rodrigues; Adriane R Todeschini; Wagner B Dias Journal: J Bioenerg Biomembr Date: 2018-01-11 Impact factor: 2.945
Authors: Adedayo A Onitilo; Jessica M Engel; Ingrid Glurich; Rachel V Stankowski; Gail M Williams; Suhail A Doi Journal: Cancer Causes Control Date: 2012-05-03 Impact factor: 2.506
Authors: Jaclyn L F Bosco; Julie R Palmer; Deborah A Boggs; Elizabeth E Hatch; Lynn Rosenberg Journal: Breast Cancer Res Treat Date: 2012-06-19 Impact factor: 4.872
Authors: Dana E Rollison; Anna R Giuliano; Thomas A Sellers; Christine Laronga; Carol Sweeney; Betsy Risendal; Kathy B Baumgartner; Tim Byers; Martha L Slattery Journal: Am J Epidemiol Date: 2007-11-21 Impact factor: 4.897
Authors: Xilin Yang; Hailu Zhao; Yi Sui; Ronald C W Ma; Wing Yee So; Gary T C Ko; Alice P S Kong; Risa Ozaki; Chun Yip Yeung; Gang Xu; Peter C Y Tong; Juliana C N Chan Journal: Diabetes Date: 2009-04-28 Impact factor: 9.461